QP75-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Weight Loss Agents

QP73-21 Medical Drug Update – RSV Health Alert and Palivizumab (Synagis)

Proton Pump Inhibitors (PPIs) - Medicaid

Quantity Limit

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors - Medicaid

Prior Authorization, Quantity Limit

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors - Commercial

Prior Authorization, Quantity Limit

Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) - Commercial

Prior Authorization, Quantity Limit

Constipation Agents - Medicaid

Prior Authorization, Quantity Limit

Constipation Agents - Commercial

Prior Authorization, Quantity Limit

Compounded Medications - Commercial

Formulary Exception, Coverage Exception

Anti-Influenza Agents - Commercial

Quantity Limit